Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Herchenhorn

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|November 6, 2008
Impact of previous tracheotomy as a prognostic factor in patients with locally advanced squamous cell carcinoma of the larynx submitted to concomitant chemotherapy and radiationDaniel Herchenhorn, Fernando L Dias, Carlos G Ferreira, et al.
Clinical Genitourinary Cancer|October 20, 2023
Outcomes of Patients With Advanced Renal Cell Carcinoma With Non-Clear Cell Histology Treated With Systemic TherapyDanielle Urman, Leah Deshler, Nicole Weise, et al.
Hepato-Gastroenterology|November 2, 2010
Colorectal GISTs: from presentation to survival. An analysis of 13 casesEduardo Linhares, Daniel Herchenhorn, Carlos Gil, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|November 6, 2007
Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinomaDaniel Herchenhorn, Rodrigo Dienstmann, Fabio A Peixoto, et al.
Oral Oncology|July 10, 2017
Long-term survival of a randomized phase III trial of head and neck cancer patients receiving concurrent chemoradiation therapy with or without low-level laser therapy (LLLT) to prevent oral mucositisHéliton S Antunes, Daniel Herchenhorn, Isabele A Small, et al.
Revista Do Colegio Brasileiro De Cirurgioes|January 24, 2012
Gastrointestinal stromal tumor: analysis of 146 cases of the center of reference of the National Cancer Institute--INCAEduardo Linhares, Rinaldo Gonçalves, Marcus Valadão, et al.
The Prostate|September 23, 2024
Bipolar androgen therapy for treatment of metastatic castration-resistant prostate cancer: A case seriesElizabeth U Tran, Eric Royz, Kyra Yamamoto, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|August 9, 2018
Impact of 68GA-PSMA PET / CT on treatment of patients with recurrent / metastatic high risk prostate cancer - a multicenter studyAline B Mattiolli, Allan Santos, Andreia Vicente, et al.
JCO Global Oncology|March 31, 2026
Optimizing the Systemic Treatment for Metastatic Castration-Resistant Prostate Cancer in Lower-Middle-Income Countries: A 7-Year Analysis of the Brazilian Public Health SystemFernando Sabino Marques Monteiro, Vinicius Carrera Souza, Karine Martins da Trindade, et al.
Urologic Oncology|June 17, 2008
XAF1 mRNA expression improves progression-free and overall survival for patients with advanced bladder cancer treated with neoadjuvant chemotherapyMarcos B Pinho, Fernanda Costas, João Sellos, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|November 6, 2008
Impact of previous tracheotomy as a prognostic factor in patients with locally advanced squamous cell carcinoma of the larynx submitted to concomitant chemotherapy and radiationDaniel Herchenhorn, Fernando L Dias, Carlos G Ferreira, et al.
Clinical Genitourinary Cancer|October 20, 2023
Outcomes of Patients With Advanced Renal Cell Carcinoma With Non-Clear Cell Histology Treated With Systemic TherapyDanielle Urman, Leah Deshler, Nicole Weise, et al.
Hepato-Gastroenterology|November 2, 2010
Colorectal GISTs: from presentation to survival. An analysis of 13 casesEduardo Linhares, Daniel Herchenhorn, Carlos Gil, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|November 6, 2007
Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinomaDaniel Herchenhorn, Rodrigo Dienstmann, Fabio A Peixoto, et al.
Oral Oncology|July 10, 2017
Long-term survival of a randomized phase III trial of head and neck cancer patients receiving concurrent chemoradiation therapy with or without low-level laser therapy (LLLT) to prevent oral mucositisHéliton S Antunes, Daniel Herchenhorn, Isabele A Small, et al.
Revista Do Colegio Brasileiro De Cirurgioes|January 24, 2012
Gastrointestinal stromal tumor: analysis of 146 cases of the center of reference of the National Cancer Institute--INCAEduardo Linhares, Rinaldo Gonçalves, Marcus Valadão, et al.
The Prostate|September 23, 2024
Bipolar androgen therapy for treatment of metastatic castration-resistant prostate cancer: A case seriesElizabeth U Tran, Eric Royz, Kyra Yamamoto, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|August 9, 2018
Impact of 68GA-PSMA PET / CT on treatment of patients with recurrent / metastatic high risk prostate cancer - a multicenter studyAline B Mattiolli, Allan Santos, Andreia Vicente, et al.
JCO Global Oncology|March 31, 2026
Optimizing the Systemic Treatment for Metastatic Castration-Resistant Prostate Cancer in Lower-Middle-Income Countries: A 7-Year Analysis of the Brazilian Public Health SystemFernando Sabino Marques Monteiro, Vinicius Carrera Souza, Karine Martins da Trindade, et al.
Urologic Oncology|June 17, 2008
XAF1 mRNA expression improves progression-free and overall survival for patients with advanced bladder cancer treated with neoadjuvant chemotherapyMarcos B Pinho, Fernanda Costas, João Sellos, et al.
Pageof 6